Trokendi XR
Failed dissolution specifications.
Yes — there is an active recall. 2 ongoing FDA recalls mention Topiramate (11 total). Check the affected lots below.
Most common reason: Dissolution failure (2 of these recalls)
Recalls are matched by product description. A recall usually affects specific lots, not every package of Topiramate. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.
Failed dissolution specifications.
Failed Dissolution Specifications
Failed Impurities/Degradation Specifications: Out of specification Impurity C (4,5-desisopropylidene topiramate) result observed during routine stability testing at 18 months.
Discoloration
CGMP Deviations: Intermittent exposure to temperature excursion during storage.
CGMP Deviations: Light sensitive drug products repackaged in transparent/partially transparent pouches.
Superpotent Drug: Failure of assay specifications in the capsule.
Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.
Presence of Foreign Tablets: Presence of topiramate 100 mg tablets comingled with 200 mg tablets.
Chemical Contamination: Topiramate Tablets is being recalled due to complaints related to an off - odor. described as moldy, musty or fishy in nature.
Labeling: Label Mix-Up: A typographical error in the product form on the carton label incorrectly lists the configuration as 30 "Capsules" (3 x 10) rather than "Tablets".
Free recall alerts
Tell us what you take. When FDA posts a recall announcement or classifies a recall for one of your medications, we email you in plain English, with what to check. No account needed.